Concurrent Investment Advisors’s Exelixis EXEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.24M Sell
22,791
-14,196
-38% -$691K 0.01% 912
2026
Q1
$1.59M Buy
36,987
+5,566
+18% +$239K 0.02% 694
2025
Q4
$1.38M Buy
31,421
+7,512
+31% +$311K 0.02% 703
2025
Q3
$987K Buy
23,909
+5,183
+28% +$208K 0.02% 660
2025
Q2
$825K Buy
18,726
+6,344
+51% +$254K 0.02% 657
2025
Q1
$457K Buy
+12,382
New +$441K 0.01% 773

Other funds holding EXEL

Concurrent Investment Advisors's EXEL Position: Q2 2026 in Review

Concurrent Investment Advisors reduced its Exelixis (EXEL) stake by 38% in Q2 2026, selling an estimated $691K and leaving 22,791 shares worth $1.24M. The position accounts for 0.01% of the portfolio, ranked #912.

Concurrent Investment Advisors first reported a position in EXEL in Q1 2025 and has held it in 6 quarters since. The position peaked at $1.59M in Q1 2026. 760 funds tracked by Wall St. Rank hold EXEL as of Q2 2026.

  • Concurrent Investment Advisors held 22,791 shares of Exelixis worth $1.24M as of Q2 2026.
  • Concurrent Investment Advisors sold 14,196 Exelixis shares in Q2 2026, an estimated $691K.
  • Exelixis made up 0.01% of Concurrent Investment Advisors's portfolio in Q2 2026, its #912 holding.
  • Concurrent Investment Advisors first reported a position in Exelixis in Q1 2025 and has held it in 6 quarters since.
  • Concurrent Investment Advisors's Exelixis position peaked at $1.59M in Q1 2026.
  • 760 funds tracked by Wall St. Rank held Exelixis as of Q2 2026.

Based on Concurrent Investment Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.